Disclaimer: The views expressed in this editorial reflect the opinions of the authors only, and not the official policy of the Uniformed Services University, USA or the Department of Defense, USA.
Opioid addiction agonist therapy and the QT prolongation phenomenon: state of the science and evolving research questions
Version of Record online: 10 MAY 2013
© 2013 The Authors, Addiction © 2013 Society for the Study of Addiction
Volume 108, Issue 6, pages 1015–1017, June 2013
How to Cite
Wedam, E. F. and Haigney, M. C. (2013), Opioid addiction agonist therapy and the QT prolongation phenomenon: state of the science and evolving research questions. Addiction, 108: 1015–1017. doi: 10.1111/add.12123
- Issue online: 10 MAY 2013
- Version of Record online: 10 MAY 2013
- 11Centers for Disease Control and Prevention (CDC). Vital signs: risk for overdose from methadone used for pain relief—United States, 1999–2010. Morb Mortal Wkly Rep 2012; 61: 493–497.
- 13Methadone-associated ventricular arrhythmia fatalities reported to the FDA from 1969–2011. Heart Rhythm 2012; 9: S89. AB40–05 [Abstract]., , , ,
- 15American Heart Association Acute Cardiac Care Committee of the Council on Clinical Cardiology; Council on Cardiovascular Nursing, American College of Cardiology Foundation. Prevention of torsade de pointes in hospital settings: a scientific statement from the American Heart Association and the American College of Cardiology Foundation. Circulation 2010; 121: 1047–1060., , , , , et al.,